| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/03/1993 | EP0524946A1 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| 02/03/1993 | CN1068570A Antiviral combinations |
| 02/02/1993 | US5183925 Leukotriene-b4 derivatives, process for their production and their use as pharmaceutical agents |
| 02/02/1993 | US5183822 Substituted 3,4-annelated benzimidazol-2(1h)-ones |
| 02/02/1993 | US5183805 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/02/1993 | CA1313371C Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation |
| 02/02/1993 | CA1313370C Cyclopolyglycuronic acid composition and treatment |
| 02/01/1993 | CA2075102A1 6-oxoazepinoindole compounds, processes and intermediates for their preparation and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074788A1 Qinolin-2-yl-methoxybenzylhydroxyureas |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/31/1993 | CA2074846A1 "2-(imidazol-1-yl)-2-benzylethylidene-aminoxyalkanoic acid derivatives" |
| 01/31/1993 | CA2074797A1 Certain heteroaryl substituted hydroxylamine derivatives |
| 01/30/1993 | CA2074542A1 Sulphur containing non-steroidal drugs as 5-alpha reductase inhibitors |
| 01/28/1993 | CA2092408A1 Radioprotection by calcium antagonists |
| 01/28/1993 | CA2074685A1 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds |
| 01/28/1993 | CA2072529A1 2-piperidinylpyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics |
| 01/27/1993 | EP0524796A1 Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS |
| 01/27/1993 | EP0524742A2 Benzo(a)fluorene compounds |
| 01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
| 01/27/1993 | EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 01/27/1993 | EP0524517A1 Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation |
| 01/27/1993 | CN1068251A Production process of compound gynostemma pentaphylla tea |
| 01/26/1993 | US5182288 Substituted n-biphenylyl lactams |
| 01/26/1993 | US5182283 Alzheimer's disease |
| 01/26/1993 | US5182280 Derivatives of benzimidazole and their use as antihistamines |
| 01/26/1993 | US5182261 Modified transforming growth factor alpha oligopeptides and pharmaceutical compositions thereof |
| 01/26/1993 | US5182106 Method for treating hypothermia |
| 01/26/1993 | CA1313140C Pharmaceutical composition containing cimetidine |
| 01/26/1993 | CA1313137C Method of inhibiting interleukin-1 activity |
| 01/25/1993 | CA2073913A1 Preparation of fatty acid medicaments |
| 01/24/1993 | CA2070495A1 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/23/1993 | CA2074211A1 Arylalkylamine derivatives |
| 01/23/1993 | CA2073488A1 Benzo (a) fluorene compounds |
| 01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/21/1993 | WO1993001197A1 Derivatives of inositol, preparations containing them and their use |
| 01/21/1993 | WO1993001182A1 Methylen-oxindole derivatives and process for their preparation |
| 01/21/1993 | WO1993001177A1 Substituted triazolinones |
| 01/21/1993 | WO1993001160A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993000917A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | WO1992019211A3 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same |
| 01/21/1993 | CA2112473A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | CA2110513A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/20/1993 | WO1993002096A1 PROCESS FOR THE PREPARATION OF 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES |
| 01/20/1993 | WO1993002037A1 Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 01/20/1993 | EP0524146A1 Aminosubstituted Piperazinederivatives |
| 01/20/1993 | EP0524004A1 Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo[2,3-e]quinolizine derivatives |
| 01/20/1993 | EP0523948A2 Method for improving the cancer cell-killing activity of lymphocytes |
| 01/20/1993 | EP0523688A1 Process for the preparation of 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives |
| 01/20/1993 | EP0523138A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes |
| 01/20/1993 | EP0523046A1 2-anilino phenylacetic acid derivatives as inhibitors of pla 2? and lipoxygenase |
| 01/20/1993 | EP0379511B1 Polypeptides with laminin activity |
| 01/20/1993 | EP0359739B1 Tranforming growth factor-beta |
| 01/20/1993 | CN1068117A Heterocyclic compounds with renin-inhibiting properties, process for preparation thereof and use thereof |
| 01/20/1993 | CN1068112A Compounds with renin-inhibiting properties, process for the preparation thereof and use thereof |
| 01/20/1993 | CN1068033A Method and composition for ameliorating adverse effects of aging |
| 01/20/1993 | CA2102122A1 Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 01/20/1993 | CA2091983A1 Process for the preparation of 17.beta.-substituted-4-aza-5.alpha.-androstan-3-one derivatives |
| 01/20/1993 | CA2074154A1 Amino-substituted piperazine derivatives |
| 01/19/1993 | US5180743 Treatment of rheumatoid arthritis, ant venom extract |
| 01/19/1993 | US5180742 Lipoxygenase Inhibitors |
| 01/19/1993 | US5180733 Biogenic amine uptake inhibitors |
| 01/19/1993 | US5180728 Pyrimidoindole derivatives and processes for preparation thereof |
| 01/19/1993 | US5180723 Certain sulfonamide heterobicyclic platelet activating factor antagonists |
| 01/19/1993 | CA1312870C Alkanesulfonamides as antiglaucoma agents |
| 01/19/1993 | CA1312866C Benzo¬b|pyranes and pyranopyridines, process for their production and their use |
| 01/19/1993 | CA1312860C Process for preparation of aloe products |
| 01/18/1993 | CA2074038A1 Decahydro-8h-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a] pyrrol[2,3-e]quinolizine derivatives |
| 01/14/1993 | DE4123587A1 2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln 2,14-disubstituted ergoline, their production and use in medicinal products |
| 01/13/1993 | WO1993001185A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 01/13/1993 | EP0522914A1 2-Piperidinylpyrimidin-4-carboxamide derivatives, their preparation and their application in therapy |
| 01/13/1993 | EP0522808A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/13/1993 | EP0522715A1 Squalene synthethase inhibitors and processes therefrom |
| 01/13/1993 | EP0522576A2 Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use |
| 01/13/1993 | EP0522494A1 Novel isatineoxime derivatives, their preparation and use |
| 01/13/1993 | EP0522080A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| 01/13/1993 | EP0522070A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM) |
| 01/13/1993 | EP0522004A1 Use of copper(ii) containing compounds to accelerate wound healing |
| 01/13/1993 | EP0522000A1 5-lipoxygenase inhibitors |
| 01/13/1993 | EP0521986A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| 01/13/1993 | EP0521974A1 Veterinary treatment. |
| 01/13/1993 | EP0329708B1 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
| 01/13/1993 | EP0259440B1 Method of stimulating melanocytes by topical application of analogs of alpha-msh, and compositions for use in same |
| 01/13/1993 | CN1067893A Heterocyclic derivatives |
| 01/13/1993 | CN1067888A Derivatives of 2-piperidylpyrimidine-4-carboxamide, its preparation and its application in therapeutics |
| 01/13/1993 | CA2091455A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 01/12/1993 | US5179108 Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application |
| 01/12/1993 | US5178873 For inhibiting phospholipase; administering stearidonic acid |
| 01/12/1993 | CA1312704C Grf analogs vii |
| 01/12/1993 | CA1312608C Unsaturated phosphonic acids and derivatives |
| 01/11/1993 | CA2073499A1 Inhibitors of hiv protease useful for the treatment of aids |
| 01/11/1993 | CA2071137A1 Composition and method for revitalizing scar tissue |
| 01/10/1993 | CA2073396A1 Pharmaceutical agent for treatment of withdrawal symptons |
| 01/10/1993 | CA2073281A1 Isatineoxime derivatives, their preparation and use |
| 01/09/1993 | WO1993000921A1 Remedy for osteoporosis |
| 01/09/1993 | CA2090453A1 Remedy for osteoporosis |
| 01/07/1993 | WO1993000432A1 Bmp-9 compositions |
| 01/07/1993 | WO1993000348A1 Dimethylamino-hydroxy-alkan diphosphonic acids and pharmaceutical compositions containing them |
| 01/07/1993 | WO1993000339A1 A novel salicylic acid-maltol conjugates |
| 01/07/1993 | WO1993000332A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |